4/A//SEC Filing
Miller Matthew P 4/A
Accession 0001628280-22-007763
CIK 0001799191other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 8:11 PM ET
Size
8.5 KB
Accession
0001628280-22-007763
Insider Transaction Report
Form 4/AAmended
Miller Matthew P
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-21+109,844→ 109,844 totalExercise: $7.09Exp: 2032-03-21→ Common stock (109,844 underlying) - Award
Stock Option (right to buy)
2022-03-21+32,417→ 32,417 totalExercise: $7.09Exp: 2032-03-21→ Common stock (32,417 underlying)
Footnotes (2)
- [F1]The stock options vest in four equal annual installments on each of the first four anniversaries of November 12, 2021 (the "Vesting Commencement Date"), with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
- [F2]The stock options vest as to 1/3rd of the options granted on the second anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001915822
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 8:11 PM ET
- Size
- 8.5 KB